<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="referrer" content="no-referrer" />
  <meta name="description" content="Seke Keretsu." />

  <title>STING</title>

  <!-- Shared site styling -->
  <link rel="stylesheet" href="assets/site.css" />

  <!-- Small page-specific styling (optional) -->
  <style>
    hr{
      border: 0;
      border-top: 1px solid var(--border);
      margin: 1.25rem 0;
    }
    .hero-title{
      margin: 0 0 .75rem;
    }
    .figure-img{
      display: block;
      width: 100%;
      max-width: 900px;
      margin: .75rem auto 1rem;
      border-radius: 12px;
      border: 1px solid var(--border);
      box-shadow: 0 8px 20px rgba(0,0,0,.08);
    }
    .figure-caption{
      color: var(--muted);
      font-size: .95rem;
      margin-top: .5rem;
      text-align: center;
    }
    .refs{
      font-size: 0.98rem;
    }
    .refs p{
      text-align: left;
      hyphens: none;
    }
  </style>
</head>

<body>
  <nav class="topnav" aria-label="Primary navigation">
    <div class="inner">
      <a href="index.html">Home</a>
      <a class="active" href="research.html">Research</a>
      <a href="publication.html">Publication</a>
      <a href="software.html">Software</a>
      <a href="tutorial.html">Tutorial</a>
      <a href="contact.html">Contact</a>
      <a href="blog.html">Blog</a>
    </div>
  </nav>

  <main class="container">
    <section class="card">
      <h1 class="hero-title">
        Title: Discovery of small molecules and dinucleotide analogs as STING agonist for cancer immunotherapy.
      </h1>
      <hr>

      <h2>Introduction</h2>
      <p>
        Immune evasion via T cell exhaustion, secretion of immunosuppressive mediators and expression of proteins that
        modulate immune checkpoint, is a well-established hallmark for cancer (1). T cell infiltration to the tumor
        microenvironment has been considered to be a prerequisite for an efficient response to immunotherapeutic
        treatment (2,3). Hence, redirecting the immune response to the tumor microenvironment has been considered an
        important therapeutic route for cancer treatment (2).
      </p>
      <p>
        The enzyme cyclic-GMP-AMP synthase (cGAS) detects cytoplasmic self DNA or tumor-derived DNA and generates the
        secondary messenger cyclic Guanosine Monophosphate–Adenosine Monophosphate (cGAMP) (4). cGAMP binds to the
        stimulator of interferon genes (STING) and activates it. STING then recruits tank-binding kinase 1 (TBK1) and
        activates interferon regulatory factor (IRF3) which triggers a cascade of downstream signaling events responsible
        for activation and infiltration of T cells into the tumor microenvironment and promotes antitumor responses.
        Hence, STING agonists with the potential to induce immune response are promising drug candidates for cancer (2,5,6).
      </p>
      <p>
        The objective of this proposal is to determine the mechanism of STING activation by its endogenous ligand cGAMP
        at the molecular level and to develop novel STING agonists using state-of-the-art computer-aided drug design
        (CADD) techniques such as molecular docking, pharmacophore modeling, virtual screening, classical molecular
        dynamics (MD) and binding energy calculation (7–9).
      </p>

      <figure>
        <img class="figure-img" src="sting.jpg" alt="STING pathway and structural figures" />
        <figcaption class="figure-caption">
          <strong>Figure 1.</strong> (A) The cGAS–STING–IRF3 immune signaling pathway (adapted from Ref. (17)).
          (B) Apo STING homodimer (PDB 6NT5) aligned with cGAMP–STING complex (PDB 4KSY).
          (C) Endogenous ligand (2’,3’-cGAMP). (D) Strategy for cyclic dinucleotide analog design.
        </figcaption>
      </figure>

      <hr>

      <p><strong>Aim 1: To determine the mechanism of activation of STING by the endogenous cyclic dinucleotide 2’, 3’-cGAMP.</strong></p>
      <p>
        The stimulator of interferon genes (STIN
